Daily FNArena News - Small Caps

Telix Pharmaceuticals’ prostate cancer imaging product Illucix is quickly conquering the USA, but management at the firm has (much) higher ambitions

A strong finish to the year looks to provide Corporate Travel Management with momentum as it moves into the new year, and should see the company benefit as markets reopen

Having delivered record sales in FY22, significant growth continues for Baby Bunting as the company pursues a bigger share of the domestic baby goods market through growth initiatives

FY22 results for Australian Clinical Labs missed expectations and brokers await an uptick in non-covid testing

Megaport’s FY22 result highlighted significant metrics disclosed for the first time, underpinning broker views of a solid longer term growth story

Dedicated lung imaging pioneer 4D medical sees itself as a software company, with lots of future potential, including from the US military

Brokers set lower price targets for Nitro Software on lower growth expectations after a trading update surprised negatively

Micro-cap biotech Orthocell is aiming to emulate the successful growth story of Polynovo, nowadays capitalised at $1.1bn

Increasing frequency and intensity of catastrophic events is good news for Johns Lyng Group’s growth, as the company delivered a record half in catastrophe works revenue

Broker opinions vary widely on the outlook for Limeade after FY21 results highlighted a lack of organic growth but with emerging positive signs